लोड हो रहा है...
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Dabigatran is an oral anticoagulant that is increasingly used for atrial fibrillation (AF). Presently, many authorities state that routine laboratory coagulation monitoring is not required. However, data have recently been published demonstrating that higher trough plasma dabigatran concentrations a...
में बचाया:
में प्रकाशित: | Br J Clin Pharmacol |
---|---|
मुख्य लेखकों: | , , , , |
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
BlackWell Publishing Ltd
2014
|
विषय: | |
ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243910/ https://ncbi.nlm.nih.gov/pubmed/24592851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12364 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|